| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 45.227 | 17.152 | 16.017 | 25.898 | 39.627 | 36.725 | 28.194 | 23.284 |
| Total Income - EUR | - | - | 45.227 | 17.152 | 16.029 | 25.898 | 39.628 | 36.844 | 28.553 | 23.323 |
| Total Expenses - EUR | - | - | 1.669 | 18.107 | 21.024 | 15.152 | 20.992 | 25.591 | 29.157 | 29.043 |
| Gross Profit/Loss - EUR | - | - | 43.559 | -955 | -4.995 | 10.745 | 18.636 | 11.253 | -603 | -5.720 |
| Net Profit/Loss - EUR | - | - | 42.215 | -1.469 | -5.155 | 10.589 | 18.394 | 10.941 | -834 | -5.941 |
| Employees | - | - | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Metabolic Syndrome Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2.783 | 2.990 | 4.098 | 2.506 | 3.172 | 2.327 | 1.243 | 312 |
| Current Assets | - | - | 40.253 | 14.945 | 4.768 | 16.419 | 34.923 | 42.341 | 29.156 | 27.418 |
| Inventories | - | - | 0 | 24 | 24 | 24 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 25 | 8 | 8 | 91 | 319 | 1.399 | 1.558 | 1.596 |
| Cash | - | - | 40.228 | 14.913 | 4.737 | 16.305 | 34.604 | 40.943 | 27.598 | 25.822 |
| Shareholders Funds | - | - | 42.259 | 17.394 | 8.575 | 19.001 | 36.974 | 43.761 | 27.541 | 21.446 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 778 | 571 | 417 | 8 | 1.219 | 1.144 | 3.056 | 6.455 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Metabolic Syndrome Srl